Endohepatology: Where Can EUS Take Us?

AUGUST 22, 2025

AGA Accepting Applications for Its Inaugural Incubator Program

AUGUST 21, 2025

Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis

AUGUST 20, 2025

Email This Article

POSTED: JANUARY 29, 2018

Lutathera Approved to Treat Gastroenteropancreatic NETs

The FDA has approved lutetium Lu 177 dotatate (Lutathera, Advanced Accelerator Applications) for the treatment of somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors in adults.
A link to this article will be included in this email.

Recipient's Email Address:

Enter email addresses separated by commas if sending to more than one person. (200 characters max)

Your Name:

Your Email Address:

Send me a copy

Personal Message: (Optional)

These email addresses will only be used to send out this message.

Please wait..

FDA Update & Product News

JANUARY 29, 2018

Lutathera Approved to Treat Gastroenteropancreatic NETs

To read the full story, Log in or Sign up for a Free Account

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select